Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List
| Dataset | double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_8d_versus_double_gel_24h.class.cls #double_gel_8d_versus_double_gel_24h_repos |
| Phenotype | class.cls#double_gel_8d_versus_double_gel_24h_repos |
| Upregulated in class | double_gel_8d |
| GeneSet | GERY_CEBP_TARGETS |
| Enrichment Score (ES) | 0.5302282 |
| Normalized Enrichment Score (NES) | 1.8267677 |
| Nominal p-value | 0.0 |
| FDR q-value | 0.02305606 |
| FWER p-Value | 0.872 |
| PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|---|---|
| 1 | FOS | FOS Entrez, Source | v-fos FBJ murine osteosarcoma viral oncogene homolog | 3 | 1.622 | 0.0929 | Yes |
| 2 | RGS2 | RGS2 Entrez, Source | regulator of G-protein signalling 2, 24kDa | 50 | 0.810 | 0.1359 | Yes |
| 3 | PROCR | PROCR Entrez, Source | protein C receptor, endothelial (EPCR) | 59 | 0.763 | 0.1790 | Yes |
| 4 | CRYAB | CRYAB Entrez, Source | crystallin, alpha B | 62 | 0.756 | 0.2223 | Yes |
| 5 | DBP | DBP Entrez, Source | D site of albumin promoter (albumin D-box) binding protein | 87 | 0.682 | 0.2596 | Yes |
| 6 | LPL | LPL Entrez, Source | lipoprotein lipase | 107 | 0.646 | 0.2953 | Yes |
| 7 | TNFAIP6 | TNFAIP6 Entrez, Source | tumor necrosis factor, alpha-induced protein 6 | 159 | 0.550 | 0.3230 | Yes |
| 8 | RGS16 | RGS16 Entrez, Source | regulator of G-protein signalling 16 | 205 | 0.482 | 0.3473 | Yes |
| 9 | KLF4 | KLF4 Entrez, Source | Kruppel-like factor 4 (gut) | 255 | 0.437 | 0.3687 | Yes |
| 10 | PRNP | PRNP Entrez, Source | prion protein (p27-30) (Creutzfeldt-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia) | 290 | 0.408 | 0.3895 | Yes |
| 11 | PLAT | PLAT Entrez, Source | plasminogen activator, tissue | 321 | 0.383 | 0.4092 | Yes |
| 12 | ECHS1 | ECHS1 Entrez, Source | enoyl Coenzyme A hydratase, short chain, 1, mitochondrial | 346 | 0.367 | 0.4285 | Yes |
| 13 | ELOVL6 | ELOVL6 Entrez, Source | ELOVL family member 6, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast) | 433 | 0.319 | 0.4403 | Yes |
| 14 | CXCL1 | CXCL1 Entrez, Source | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 474 | 0.294 | 0.4542 | Yes |
| 15 | LSS | LSS Entrez, Source | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | 531 | 0.275 | 0.4658 | Yes |
| 16 | S100A8 | S100A8 Entrez, Source | S100 calcium binding protein A8 | 725 | 0.231 | 0.4644 | Yes |
| 17 | BAIAP2 | BAIAP2 Entrez, Source | BAI1-associated protein 2 | 768 | 0.222 | 0.4740 | Yes |
| 18 | MKNK2 | MKNK2 Entrez, Source | MAP kinase interacting serine/threonine kinase 2 | 842 | 0.206 | 0.4803 | Yes |
| 19 | BCKDHB | BCKDHB Entrez, Source | branched chain keto acid dehydrogenase E1, beta polypeptide (maple syrup urine disease) | 906 | 0.195 | 0.4867 | Yes |
| 20 | APBB1IP | APBB1IP Entrez, Source | amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | 917 | 0.193 | 0.4971 | Yes |
| 21 | ANGPTL4 | ANGPTL4 Entrez, Source | angiopoietin-like 4 | 988 | 0.184 | 0.5023 | Yes |
| 22 | NSDHL | NSDHL Entrez, Source | NAD(P) dependent steroid dehydrogenase-like | 1169 | 0.164 | 0.4981 | Yes |
| 23 | IGF2 | IGF2 Entrez, Source | insulin-like growth factor 2 (somatomedin A) | 1190 | 0.162 | 0.5059 | Yes |
| 24 | DUSP1 | DUSP1 Entrez, Source | dual specificity phosphatase 1 | 1266 | 0.154 | 0.5091 | Yes |
| 25 | ABCA1 | ABCA1 Entrez, Source | ATP-binding cassette, sub-family A (ABC1), member 1 | 1319 | 0.149 | 0.5137 | Yes |
| 26 | RASL11B | RASL11B Entrez, Source | RAS-like, family 11, member B | 1364 | 0.146 | 0.5188 | Yes |
| 27 | S100A3 | S100A3 Entrez, Source | S100 calcium binding protein A3 | 1425 | 0.141 | 0.5223 | Yes |
| 28 | ALDH3A1 | ALDH3A1 Entrez, Source | aldehyde dehydrogenase 3 family, memberA1 | 1428 | 0.140 | 0.5302 | Yes |
| 29 | ACSL1 | ACSL1 Entrez, Source | acyl-CoA synthetase long-chain family member 1 | 1627 | 0.127 | 0.5226 | No |
| 30 | EREG | EREG Entrez, Source | epiregulin | 1968 | 0.109 | 0.5032 | No |
| 31 | MVD | MVD Entrez, Source | mevalonate (diphospho) decarboxylase | 1998 | 0.108 | 0.5072 | No |
| 32 | ATF3 | ATF3 Entrez, Source | activating transcription factor 3 | 2035 | 0.106 | 0.5105 | No |
| 33 | HP | HP Entrez, Source | haptoglobin | 2342 | 0.094 | 0.4928 | No |
| 34 | PEA15 | PEA15 Entrez, Source | phosphoprotein enriched in astrocytes 15 | 2496 | 0.088 | 0.4863 | No |
| 35 | IER2 | IER2 Entrez, Source | immediate early response 2 | 2518 | 0.087 | 0.4898 | No |
| 36 | JUNB | JUNB Entrez, Source | jun B proto-oncogene | 2752 | 0.078 | 0.4767 | No |
| 37 | C3 | C3 Entrez, Source | complement component 3 | 2945 | 0.073 | 0.4664 | No |
| 38 | FOXG1 | 3032 | 0.070 | 0.4639 | No | ||
| 39 | FGF7 | FGF7 Entrez, Source | fibroblast growth factor 7 (keratinocyte growth factor) | 3188 | 0.066 | 0.4560 | No |
| 40 | CXCL5 | CXCL5 Entrez, Source | chemokine (C-X-C motif) ligand 5 | 3208 | 0.065 | 0.4583 | No |
| 41 | IFRD1 | IFRD1 Entrez, Source | interferon-related developmental regulator 1 | 3472 | 0.058 | 0.4419 | No |
| 42 | ID3 | ID3 Entrez, Source | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 3479 | 0.058 | 0.4448 | No |
| 43 | BTG2 | BTG2 Entrez, Source | BTG family, member 2 | 3759 | 0.051 | 0.4266 | No |
| 44 | SH3GL3 | SH3GL3 Entrez, Source | SH3-domain GRB2-like 3 | 4015 | 0.044 | 0.4099 | No |
| 45 | NR2F6 | NR2F6 Entrez, Source | nuclear receptor subfamily 2, group F, member 6 | 4809 | 0.028 | 0.3517 | No |
| 46 | ACTA2 | ACTA2 Entrez, Source | actin, alpha 2, smooth muscle, aorta | 4827 | 0.027 | 0.3520 | No |
| 47 | ABCD2 | ABCD2 Entrez, Source | ATP-binding cassette, sub-family D (ALD), member 2 | 5216 | 0.020 | 0.3239 | No |
| 48 | CLU | CLU Entrez, Source | clusterin | 5443 | 0.016 | 0.3078 | No |
| 49 | RRAD | RRAD Entrez, Source | Ras-related associated with diabetes | 5502 | 0.015 | 0.3042 | No |
| 50 | SERPINI1 | SERPINI1 Entrez, Source | serpin peptidase inhibitor, clade I (neuroserpin), member 1 | 5563 | 0.013 | 0.3005 | No |
| 51 | ORM1 | ORM1 Entrez, Source | orosomucoid 1 | 5606 | 0.013 | 0.2980 | No |
| 52 | CD1D1 | 5665 | 0.012 | 0.2943 | No | ||
| 53 | DNAJB9 | DNAJB9 Entrez, Source | DnaJ (Hsp40) homolog, subfamily B, member 9 | 6082 | 0.004 | 0.2632 | No |
| 54 | LCN2 | LCN2 Entrez, Source | lipocalin 2 (oncogene 24p3) | 6435 | -0.002 | 0.2368 | No |
| 55 | PPARG | PPARG Entrez, Source | peroxisome proliferative activated receptor, gamma | 6599 | -0.006 | 0.2248 | No |
| 56 | SERPINB2 | SERPINB2 Entrez, Source | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 6630 | -0.006 | 0.2229 | No |
| 57 | XDH | XDH Entrez, Source | xanthine dehydrogenase | 7075 | -0.014 | 0.1902 | No |
| 58 | DCN | DCN Entrez, Source | decorin | 7217 | -0.016 | 0.1805 | No |
| 59 | CRABP2 | CRABP2 Entrez, Source | cellular retinoic acid binding protein 2 | 7366 | -0.019 | 0.1704 | No |
| 60 | RDH11 | RDH11 Entrez, Source | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 7495 | -0.022 | 0.1620 | No |
| 61 | PER2 | PER2 Entrez, Source | period homolog 2 (Drosophila) | 7759 | -0.027 | 0.1437 | No |
| 62 | CSPG2 | CSPG2 Entrez, Source | chondroitin sulfate proteoglycan 2 (versican) | 7897 | -0.029 | 0.1350 | No |
| 63 | CD47 | CD47 Entrez, Source | CD47 molecule | 8623 | -0.044 | 0.0829 | No |
| 64 | HGF | HGF Entrez, Source | hepatocyte growth factor (hepapoietin A; scatter factor) | 8951 | -0.051 | 0.0611 | No |
| 65 | HMGCR | HMGCR Entrez, Source | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase | 8972 | -0.051 | 0.0625 | No |
| 66 | MAFK | MAFK Entrez, Source | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) | 9248 | -0.057 | 0.0450 | No |
| 67 | NRP1 | NRP1 Entrez, Source | neuropilin 1 | 10344 | -0.086 | -0.0326 | No |
| 68 | TRIB3 | TRIB3 Entrez, Source | tribbles homolog 3 (Drosophila) | 10943 | -0.106 | -0.0716 | No |
| 69 | HBEGF | HBEGF Entrez, Source | heparin-binding EGF-like growth factor | 11219 | -0.117 | -0.0857 | No |
| 70 | ID2 | ID2 Entrez, Source | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 11229 | -0.117 | -0.0796 | No |
| 71 | FHL2 | FHL2 Entrez, Source | four and a half LIM domains 2 | 11359 | -0.123 | -0.0823 | No |
| 72 | MYD116 | 11694 | -0.138 | -0.0996 | No | ||
| 73 | PLAUR | PLAUR Entrez, Source | plasminogen activator, urokinase receptor | 11843 | -0.147 | -0.1023 | No |
| 74 | GCH1 | GCH1 Entrez, Source | GTP cyclohydrolase 1 (dopa-responsive dystonia) | 12298 | -0.179 | -0.1263 | No |
| 75 | NR1D1 | NR1D1 Entrez, Source | nuclear receptor subfamily 1, group D, member 1 | 12353 | -0.184 | -0.1198 | No |
| 76 | BAG3 | BAG3 Entrez, Source | BCL2-associated athanogene 3 | 12446 | -0.193 | -0.1157 | No |
| 77 | RNH1 | RNH1 Entrez, Source | ribonuclease/angiogenin inhibitor 1 | 12694 | -0.224 | -0.1214 | No |
| 78 | GADD45B | GADD45B Entrez, Source | growth arrest and DNA-damage-inducible, beta | 12969 | -0.282 | -0.1259 | No |
| 79 | PIM1 | PIM1 Entrez, Source | pim-1 oncogene | 13014 | -0.296 | -0.1122 | No |
| 80 | ZFAND2A | ZFAND2A Entrez, Source | zinc finger, AN1-type domain 2A | 13068 | -0.314 | -0.0982 | No |
| 81 | CD68 | CD68 Entrez, Source | CD68 molecule | 13210 | -0.414 | -0.0851 | No |
| 82 | HMOX1 | HMOX1 Entrez, Source | heme oxygenase (decycling) 1 | 13267 | -0.519 | -0.0596 | No |
| 83 | DDIT3 | DDIT3 Entrez, Source | DNA-damage-inducible transcript 3 | 13285 | -0.545 | -0.0296 | No |
| 84 | GADD45G | GADD45G Entrez, Source | growth arrest and DNA-damage-inducible, gamma | 13297 | -0.589 | 0.0034 | No |
